The leptospiral antigen Lp49 is a two-domain protein with putative protein binding function

Area of Science:

• Structural Biology
• Microbiology
• Immunology

Background:

• Leptospirosis, caused by pathogenic Leptospira, is a global health concern with limited diagnostic and vaccine options.
• Early diagnosis is challenging, complicating treatment and disease management.
• Genomic studies identified surface antigens as potential targets for improved diagnostics and vaccines.

Purpose of the Study:

• To determine the crystal structure of the Leptospira interrogans surface antigen Lp49.
• To elucidate the structural basis of Lp49's potential role in host-pathogen interactions.
• To provide a structural foundation for developing new leptospirosis diagnostics and vaccines.

Main Methods:

• Crystal structure determination of Lp49 using single-wavelength anomalous diffraction (SAD).
• Refinement of the crystal structure at 2.0 Å resolution.
• Analysis of the protein's domain composition and fold.

Main Results:

• The crystal structure of Lp49 was successfully determined, revealing a two-domain architecture.
• Lp49 comprises an N-terminal immunoglobulin-like beta-sandwich domain and a C-terminal seven-bladed beta-propeller domain.
• Structural analysis identified potential protein-protein interaction sites, suggesting a role in Leptospira-host interactions.

Conclusions:

• This is the first reported crystal structure of a leptospiral antigen.
• The determined structure of Lp49 provides crucial insights into its function and potential as a diagnostic and vaccine target.
• Understanding Lp49's structure can facilitate the development of novel strategies against leptospirosis.